...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders.
【24h】

N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders.

机译:N-乙基-N-亚硝基脲小鼠突变体在行为和精神疾病的解剖。

获取原文
获取原文并翻译 | 示例
           

摘要

Twin and adoption studies have consistently implicated genetics in the aetiology of psychiatric and behavioural disorders. The identification of the genes and molecular pathways that are associated with these traits using linkage studies has been difficult because psychiatric disorders are almost always non-mendelian, heterogeneous, involve multiple genetic loci and are influenced significantly by environmental factors. Mouse models that are based on intermediate signatures of psychiatric disease and pharmacological responsiveness hold promise as a complementary approach to dissecting the molecular basis of neurobehavioural disorders. This has been made possible by the development and refinement of gene targeting technologies and the use of super-efficient chemical mutagens. N-ethyl-N-nitrosourea (ENU) mutagenesis in the mouse, when coupled to a battery of sensitive behavioural screens, is an effective way of creating and identifying novel mouse behavioural mutants. Here, the concept of screening for ENU mutants is introduced while progress with two behavioural screens, an "anxiety" screen and a circadian screen, are presented. It is hoped that the study of mouse mutants that have arisen from these screens will provide new insights into the genetic basis of abnormal behaviour and that they might lead to the development of novel therapeutic compounds for human psychiatric disease.
机译:双胞胎和收养研究一直将遗传学牵涉到精神病和行为障碍的病因中。使用连锁研究来鉴定与这些性状相关的基因和分子途径一直很困难,因为精神疾病几乎总是非孟德尔的,异质的,涉及多个遗传位点的,并且受到环境因素的显着影响。基于精神病学和药理学反应性的中间特征的小鼠模型有望作为解剖神经行为障碍分子基础的一种补充方法。通过基因靶向技术的发展和完善以及超高效化学诱变剂的使用,这已经成为可能。小鼠中的N-乙基-N-亚硝基脲(ENU)诱变,与一系列敏感的行为屏幕耦合,是创建和识别新型小鼠行为突变体的有效方法。在此,介绍了筛选ENU突变体的概念,同时介绍了两种行为筛选的进展,即“焦虑”筛选和昼夜节律筛选。希望从这些筛选中产生的小鼠突变体的研究将为异常行为的遗传基础提供新的见解,并有望导致开发用于人类精神疾病的新型治疗化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号